[Recent Research Advance to Differentiate Portal Hypertension Associated with Primary Myelofibrosis and Cirrhosis...

Area of Science:

• Hematology
• Hepatology
• Internal Medicine

Background:

• Primary myelofibrosis (PMF) and cirrhosis can present with similar clinical signs, notably splenomegaly and cytopenia, leading to diagnostic confusion.
• Portal hypertension is a common complication in both conditions, further complicating differential diagnosis.
• Accurate differentiation is crucial for appropriate patient management and therapeutic intervention.

Approach:

• This review synthesizes findings from clinical studies focusing on differentiating PMF from cirrhosis-related portal hypertension.
• It analyzes key distinctions in pathogenesis, clinical manifestations, laboratory findings, and treatment strategies.
• The goal is to enhance clinician understanding and diagnostic accuracy for PMF.

Key Points:

• Splenomegaly and cytopenia are common but not exclusive to PMF, also appearing in cirrhosis.
• Pathogenesis, specific laboratory markers, and clinical progression differ significantly between PMF and cirrhosis.
• Understanding these differences is vital for accurate diagnosis and effective treatment selection.

Conclusions:

• Distinguishing primary myelofibrosis from cirrhosis requires careful evaluation of multiple clinical and laboratory parameters.
• Improved diagnostic clarity facilitates the exploration of early screening indicators for PMF.
• This knowledge supports the clinical application of novel targeted therapies, such as ruxolitinib, for PMF management.